htmx v4.0.0-alpha3

$ALLO ALPHA3 (cema-cel): Interim futility readout Q2. Positive MRD clearance = validation for scalable allogeneic CAR-T. ALLO-329: First autoimmune PoC data H1. Could be a game-changer for rheumatology (CD19/CD70 + Dagger® tech, no harsh lympodepletion).

Allogene Therapeutics $ALLO is up 26.67% in 5 days. Pfizer owns 9.8%. Inside owners Arie Belldegrun and David Chang are back after selling Kite Pharma to Gilead for $11.9B. The next few months are pivotal, with a make or break Phase 2 ALPHA3 readout expected in H1 2026.

ラーメンスクエアの麺笑の特製醤油ラーメンとても美味い、久々に心の底からうめぇと言いたくなるラーメンだった。しかも大盛り無料だしね☆

1 in 3 #LBCL patients will see their cancer return after 1L treatment. Discover how the ALPHA3 trial design combines investigational minimal residual disease (MRD) testing technology and an “off-the-shelf” #CART product to intervene early and potentially improve cure rates. $ALLO

LBCL patients face the fear of relapse after treatment ends. Our ALPHA3 trial is working to change that by testing a therapy aimed at preventing cancer from returning. Dr. Zachary Roberts joined @katiecouric to discuss the science behind this new approach. Watch the full

Old-school earbud charm meets a strawberry treat. Alpha 3 keeps it light, lively, and deliciously clear. 🍓✨🎧 #DUNU #Alpha3 #FlatHead #Earbuds #HiFi #Minimal

https://t.co/pMMDsuVrN2

ティラノサウルス / Tyrannosaurus Alpha3.0🦖 Nanmu studio (本心楠改) ♂♀

GM frens Say it back

Proud to showcase our pivotal Phase 2 ALPHA3 study with a Trial-in-Progress poster at #ASH25. ALPHA3 is designed to explore the potential of "off-the-shelf" #CAR T therapy as first-line consolidation for patients with #LBCL.  $ALLO Learn More About ALPHA3:

A new 1L consolidation approach is being studied to help predict and potentially prevent relapse in #LBCL patients following frontline therapy. Learn more about the ALPHA3 clinical trial and its potential to revolutionize patient care. #CART #celltherapy #allogeneic $ALLO Learn

For people with LBCL, the fear of relapse never goes away. The ALPHA3 trial aims to change that by testing a therapy designed to help more patients stay cancer-free. Dr. Zachary Roberts joined @katiecouric to discuss how this approach could shape the future of cancer treatment.

Join us at #ASH for an exclusive session with David Kurtz, CMO at @ForesightDx, who will present an overview of the ALPHA3 trial, a pivotal Phase 2 study evaluating cema-cel, our investigational allogeneic CAR T therapy as consolidation for MRD+ #LBCL patients. $ALLO Learn More

VERY RARE awesome Blue Screen Guard Crush death KO. SF Alpha3 Zero 3. @superloreboys @KyokujiFGC

ICYMI: @KatieCouric highlighted the ALPHA3 trial evaluating an investigational allogeneic #CART therapy to help prevent relapse in high-risk #LBCL patients - advancing innovation in cancer care. $ALLO Learn More: https://t.co/KCjqdb75X7

ティラノサウルス / Tyrannosaurus (Nanmu studio) 🦖 可動ティラノサウルス Alpha3.0 ♂♀ 映画の様な惨劇のシーンもクオリティーの高い可動フィギュアなら違和感なく再現出来ます。写真に撮って無限に遊べる恐竜フィギュア、間違いなくそれがNanmuスマートシリーズの魅力ですね！😊

Alpha 3 has officially ended for VIP readers. 😭🐺 What moment hit you the hardest? We need to know what you're still thinking about. #ChoicesGame #Alpha3

pretending idgaf so they release alpha3 faster